Board Member
Precision Biosciences Inc (DTIL)Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsMichael Amoroso is recorded as Board Member at Precision Biosciences Inc (DTIL) since March 4, 2025 and CEO at Precision Biosciences Inc (DTIL). The proxy statement of Precision Biosciences Inc reports total compensation of $2,189,467 for Michael Amoroso in fiscal 2025, including a base salary of $650,875. Disclosed compensation is on record for 5 fiscal years. Michael Amoroso has spoken on 1 investor event across 1 company, most recently for Precision Biosciences Inc on June 3, 2026. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Naresh Tanna (CFO), Alex Kelly (COO and Chief Accounting Officer) and 7 others.
“Why don't you guys introduce yourself first and I'll go last.”
2025-03-04–present
Biotechnology · Healthcare
CEO, Board Member
2025-03-04–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Precision Biosciences Inc (DTIL) | President, Chief Executive Officer and Director | $650,875 | $2,189,467 |
| 2024 | Precision Biosciences Inc (DTIL) | President, Chief Executive Officer and Director | $635,000 | $4,310,914 |
| 2023 | Precision Biosciences Inc (DTIL) | President, Chief Executive Officer and Director | $629,917 | $2,039,280 |
| 2022 | Precision Biosciences Inc (DTIL) | President, Chief Executive Officer and Director | $603,563 | $4,368,115 |
| 2021 | Precision Biosciences Inc (DTIL) | President, Chief Executive Officer and Director | $127,273 | $5,984,939 |
